The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.
Live Oak Health Sciences LOGSX
- NAV / 1-Day Return 22.31 / +0.22 %
- Total Assets 54.3 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.020%
- Distribution Fee Level Above Average
- Share Class Type Institutional
- Category Health
- Investment Style Large Blend
- Min. Initial Investment 2,000
- Status Open
- TTM Yield 0.59%
- Turnover 47%
USD | NAV as of Sep 27, 2024 | 1-Day Return as of Sep 27, 2024, 10:16 PM GMT+0
Morningstar’s Analysis LOGSX
Will LOGSX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 45.8
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Regeneron Pharmaceuticals Inc | 6.33 | 3.4 Mil | Healthcare |
McKesson Corp | 5.79 | 3.1 Mil | Healthcare |
Amgen Inc | 5.25 | 2.8 Mil | Healthcare |
Cencora Inc | 4.76 | 2.5 Mil | Healthcare |
United Therapeutics Corp | 4.49 | 2.4 Mil | Healthcare |
Intuitive Surgical Inc | 4.20 | 2.2 Mil | Healthcare |
Elevance Health Inc | 4.02 | 2.1 Mil | Healthcare |
The Cigna Group | 3.87 | 2.0 Mil | Healthcare |
Exelixis Inc | 3.57 | 1.9 Mil | Healthcare |
Thermo Fisher Scientific Inc | 3.52 | 1.9 Mil | Healthcare |